V. Vernet

589 total citations
8 papers, 231 citations indexed

About

V. Vernet is a scholar working on Molecular Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, V. Vernet has authored 8 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Medicine, 3 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in V. Vernet's work include Antibiotic Resistance in Bacteria (4 papers), Vibrio bacteria research studies (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). V. Vernet is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Vibrio bacteria research studies (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). V. Vernet collaborates with scholars based in France and New Caledonia. V. Vernet's co-authors include Joël Cousson, D. Toubas, François Vandenesch, I. Béguinot, François Delahaye, C. Delmas, C. Strady, F. Lacassin, Christine Selton‐Suty and François Alla and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, FEMS Microbiology Letters and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

V. Vernet

8 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Vernet France 7 157 95 57 48 38 8 231
R. Casillo Italy 9 238 1.5× 126 1.3× 55 1.0× 66 1.4× 20 0.5× 10 329
Paolo Carfagna Italy 11 181 1.2× 219 2.3× 45 0.8× 39 0.8× 29 0.8× 24 331
Isabel Rodríguez‐Góncer Spain 9 152 1.0× 122 1.3× 28 0.5× 43 0.9× 37 1.0× 42 295
Matti Maimets Estonia 9 69 0.4× 46 0.5× 40 0.7× 49 1.0× 12 0.3× 21 256
David Navarro Spain 9 136 0.9× 104 1.1× 23 0.4× 38 0.8× 29 0.8× 14 216
Elisa García Vázquez Spain 8 134 0.9× 111 1.2× 45 0.8× 17 0.4× 9 0.2× 20 235
Lawrence Eisenstein United States 8 90 0.6× 79 0.8× 29 0.5× 17 0.4× 38 1.0× 12 191
Ira Leviton United States 7 130 0.8× 171 1.8× 33 0.6× 42 0.9× 40 1.1× 12 332
Lucina Fossati Italy 11 101 0.6× 135 1.4× 12 0.2× 67 1.4× 36 0.9× 13 307
Zümrüt Şahbudak Bal Türkiye 8 102 0.6× 103 1.1× 17 0.3× 41 0.9× 32 0.8× 56 231

Countries citing papers authored by V. Vernet

Since Specialization
Citations

This map shows the geographic impact of V. Vernet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Vernet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Vernet more than expected).

Fields of papers citing papers by V. Vernet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Vernet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Vernet. The network helps show where V. Vernet may publish in the future.

Co-authorship network of co-authors of V. Vernet

This figure shows the co-authorship network connecting the top 25 collaborators of V. Vernet. A scholar is included among the top collaborators of V. Vernet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Vernet. V. Vernet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kernéis, Solen, Céline Plainvert, Asmaa Tazi, et al.. (2017). Clinical and microbiological features associated with group B Streptococcus bone and joint infections, France 2004–2014. European Journal of Clinical Microbiology & Infectious Diseases. 36(9). 1679–1684. 20 indexed citations
2.
Cousson, Joël, Thierry Floch, Thomas Guillard, et al.. (2015). Lung Concentrations of Ceftazidime Administered by Continuous versus Intermittent Infusion in Patients with Ventilator-Associated Pneumonia. Antimicrobial Agents and Chemotherapy. 59(4). 1905–1909. 34 indexed citations
3.
Toubas, D., C. Strady, Joël Cousson, et al.. (2011). Reactivity of (1 → 3)-β-d-glucan assay in bacterial bloodstream infections. European Journal of Clinical Microbiology & Infectious Diseases. 30(11). 1453–1460. 56 indexed citations
4.
Delahaye, François, François Alla, I. Béguinot, et al.. (2007). In-hospital mortality of infective endocarditis: Prognostic factors and evolution over an 8-year period. Scandinavian Journal of Infectious Diseases. 39(10). 849–857. 85 indexed citations
5.
Vernet, V., et al.. (1995). Virulence factors (aerobactin and mucoid phenotype) in and blood culture isolates. FEMS Microbiology Letters. 130(1). 51–57. 16 indexed citations
8.
Strady, A, et al.. (1988). [Animal bites. Epidemiology and infection risks].. PubMed. 17(42). 2229–33. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026